Effect of Initiation of Insulin Therapy on T‐lymphocyte Activation in Type 1 Diabetes
- 1 May 1990
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 7 (4) , 327-330
- https://doi.org/10.1111/j.1464-5491.1990.tb01399.x
Abstract
Levels of activated T-lymphocytes are characteristically increased in recently diagnosed patients with Type 1 diabetes and remain elevated up to 6 months after diagnosis. To determine whether insulin treatment has a role in initiating or maintaining this activation 12 patients were studied at diagnosis and again 1, 5, and 70 days after the start of insulin therapy. Levels of activated T-lymphocytes were found to be elevated at diagnosis (9.7 +/- 1.6% (+/- SD)) before insulin treatment compared with normal control subjects (4.2 +/- 1.1%; p less than 0.001). One day after starting insulin therapy, the level of activated T-lymphocytes had not changed but by day 5 it had fallen significantly (7.6 +/- 1.9%; p less than 0.05) compared with pre-treatment levels. By day 70, activated T-lymphocytes were returning towards the high levels found before treatment. Investigation of the phenotype of the activated T-lymphocytes showed that there was an increase in the percentage of activated cells expressing the CD8 (suppressor/cytotoxic) phenotype at 70 days compared with pre-treatment values (p less than 0.02). These results show that elevated levels of activated T-lymphocytes found in recently diagnosed Type 1 diabetes are not a result of insulin treatment. Treatment may, however, have a role in maintaining T-lymphocyte activation and modifying the distribution of functional subsets of the activated cells.Keywords
This publication has 14 references indexed in Scilit:
- Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetesDiabetologia, 1989
- Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1987
- Induction of Circulating Activated Suppressor-like T Cells by Methimazole Therapy for Graves' DiseaseNew England Journal of Medicine, 1987
- Impairment of Lymphocyte-Suppressive System in Recent-Onset Insulin-Dependent Diabetes Mellitus: Correlation With Metabolic ControlDiabetes, 1986
- Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic controlDiabetes, 1986
- PATHOGENESIS OF INSULIN-DEPENDENT DIABETES: A ROLE FOR ACTIVATED T LYMPHOCYTESThe Lancet, 1984
- Increased Circulating Ia-Antigen-Bearing T Cells in Type I Diabetes MellitusNew England Journal of Medicine, 1982
- Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose IntoleranceDiabetes, 1979
- Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetesDiabetologia, 1979
- ISLET-CELL ANTIBODIES IN JUVENILE DIABETES MELLITUS OF RECENT ONSETThe Lancet, 1975